 |
| 03-Jun-11 | Reiterated |
Wedbush |
Outperform |
$10 → $12 |
|
| 14-Jan-11 | Initiated |
Robert W. Baird |
Outperform |
$9 |
|
| 15-Dec-10 | Initiated |
Oppenheimer |
Outperform |
$10 |
|
| 10-Dec-10 | Initiated |
Wedbush |
Outperform |
$9 |
|
| 10-Aug-09 | Initiated |
Piper Jaffray |
Neutral |
|
|
| 02-Jul-09 | Initiated |
Lazard Capital Mkts |
Buy |
$6 |
|
| 23-May-07 | Initiated |
Dawson James |
Buy |
$5.50 |
|
| 05-Apr-07 | Initiated |
Sun Trust Rbsn Humphrey |
Buy |
$5 |
|
|
|
| 17-May-13 10:59AM | Finding Value in the Medical Products and Device Spaces: An Experienced Portfolio Manager Discusses Investing in Overlooked Health Care Areas Wall Street Transcript |
| 13-May-13 01:04AM | Here's 1 Reason Endologix Looks Weak at Motley Fool |
| 10-May-13 01:04PM | ENDOLOGIX INC /DE/ Financials EDGAR Online Financials |
| 08-May-13 04:15PM | Endologix to Participate in Three Upcoming Investor Conferences GlobeNewswire |
| 01:06AM | Is a Revenue Miss Coming for Endologix? at Motley Fool |
| 06-May-13 11:02PM | ENDOLOGIX INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 30-Apr-13 08:37PM | Endologix Earnings: Heres Why Investors are Ambivalent Now at Wall St. Cheat Sheet |
| 07:11PM | Endologix's CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 04:52PM | InPlay: Endologix misses by $0.09, beats on revs; reaffirms FY13 EPS, revs guidance Briefing.com |
| 04:50PM | Endologix Reports 22% Revenue Growth for the First Quarter 2013 GlobeNewswire |
| 09:54AM | ENDOLOGIX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online |
| 07:07AM | Q1 2013 Endologix Inc. Earnings Release - After Market Close CCBN |
| 18-Apr-13 04:33PM | ELGX Crosses Below Key Moving Average Level at TheStreet |
| 16-Apr-13 11:30AM | InPlay: Endologix announces FDA approval of first percutaneous indication for endovascular abdominal aortic aneurysm repair Briefing.com |
| 11:30AM | Endologix Announces FDA Approval of First Percutaneous Indication for Endovascular Abdominal Aortic Aneurysm Repair GlobeNewswire |
| 15-Apr-13 12:30PM | Endologix Board Member Roderick de Greef to Retire; Thomas F. Zenty, III to Stand for Election as Board Member GlobeNewswire |
| 10:20AM | ENDOLOGIX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 08-Apr-13 04:30PM | Endologix to Report First Quarter 2013 Financial Results on April 30, 2013 GlobeNewswire |
| 04-Apr-13 01:05AM | Did Endologix Squander Its Latest Sales Increase? at Motley Fool |
| 01-Apr-13 04:24PM | Endologix Shows How Growth-Hungry Med-Tech Investors Are at Seeking Alpha |
| 27-Mar-13 11:03AM | Medtronic: The Next Acquisition at Seeking Alpha |
| 01:01AM | Why Endologix May Be About to Take Off at Motley Fool |
| 21-Mar-13 07:55AM | Investing In The Medical Diagnostic Device Sector In 2013 at Seeking Alpha |
| 20-Mar-13 01:04PM | ENDOLOGIX INC /DE/ Financials EDGAR Online Financials |
| 18-Mar-13 11:41AM | Wall Street Transcript Interview with Steven M. Lichtman, Managing Director and Senior Analyst at Oppenheimer & Co. Inc.: Small and Midcap Medical Device Companies Benefit from Less Exposure to Europe Wall Street Transcript |
| 09:03AM | Costco Wholesale Director Sells 8K Shares and 4 Insider Sales to Note at Wall St. Cheat Sheet |
| 14-Mar-13 04:30PM | ENDOLOGIX INC /DE/ Files SEC form 10-K, Annual Report EDGAR Online |
| 11-Mar-13 09:00AM | Endologix to Present at the 25th Annual ROTH Conference GlobeNewswire |
| 07-Mar-13 09:02AM | The Unappreciated Awesomeness at Endologix at Motley Fool |
| 28-Feb-13 07:16PM | New Star Analyst Rankings for Endologix, Inc. StarMine |
| 27-Feb-13 10:16PM | Endologix's CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 06:42PM | Endologix Earnings: Everything You Must Know Now at Wall St. Cheat Sheet |
| 04:58PM | ENDOLOGIX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online |
| 04:45PM | Endologix Reports 27% and 25% Revenue Growth for the Full Year and Fourth Quarter 2012 GlobeNewswire |
| 07:07AM | Q4 2012 Endologix Inc. Earnings Release - After Market Close CCBN |
| 07-Feb-13 08:30AM | Endologix to Report Fourth Quarter and Full Year 2012 Financial Results on February 27, 2013 GlobeNewswire |
| 29-Jan-13 04:47AM | Buyers piling into Endologix at highs optionMONSTER |
| 28-Jan-13 08:33AM | InPlay: Endologix announces presentation of data From PEVAR randomized trial; 94% procedural technical success rate; 'significantly' reduced procedure times and time to hemostasis Briefing.com |
| 08:30AM | Endologix Announces Presentation of Data From PEVAR Randomized Trial GlobeNewswire |
| 24-Jan-13 10:16AM | InPlay: Endologix receives CE Mark for Nellix EndoVascular Aneurysm Sealing System Briefing.com |
| 10:15AM | Endologix Receives CE Mark for Nellix(R) EndoVascular Aneurysm Sealing System GlobeNewswire |
| 23-Jan-13 03:37AM | Newest Plays for Billion Dollar Bridger Management at Motley Fool |
| 18-Jan-13 09:06AM | Is Endologix Working Hard Enough for You? at Motley Fool |
| 11-Jan-13 01:12PM | Endologix: Ventana And The Day Einstein Died at Seeking Alpha |
| 09-Jan-13 04:30PM | ENDOLOGIX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 08-Jan-13 01:24PM | ENDOLOGIX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online |
| 07-Jan-13 02:37PM | ENDOLOGIX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online |
| 02:29PM | Endologix's CEO Hosts 31st Annual J.P. Morgan Healthcare Conference (Transcript) at Seeking Alpha |
| 09:00AM | Endologix Announces Preliminary Fourth Quarter 2012 Revenues GlobeNewswire |
| 03-Jan-13 04:59PM | ENDOLOGIX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 12:00PM | Endologix to Present at the 31st Annual J.P. Morgan Healthcare Conference GlobeNewswire |
| 10:36AM | McDonalds Hindered by Macro Difficulties and 4 Stock Analyses to Follow at Wall St. Cheat Sheet |
| 02-Jan-13 02:58PM | CFO Moves: Progress Software, Beacon Roofing Supply, Endologix at The Wall Street Journal |
| 01:00PM | InPlay: Endologix appoints Shelley B. Thunen Chief Financial Officer, effective immediately Briefing.com |
| 01:00PM | Endologix Appoints Shelley B. Thunen Chief Financial Officer GlobeNewswire |
| 31-Dec-12 05:58PM | J&J Gets FDA Approval for Sirturo, Lexicon Wins Fast Track for LX1033: Healthcare Business Update at Wall St. Cheat Sheet |
| 09:01AM | InPlay: Endologix IntuiTrak delivery system receives shonin approval for marketing in Japan Briefing.com |
| 09:00AM | Endologix IntuiTrak Delivery System Receives Shonin Approval for Marketing in Japan GlobeNewswire |
| 08:31AM | InPlay: Endologix comments on alleged patent infringement... 'we believe we have strong defenses and that this potential dispute will not affect our commercial operations. We intend to aggressively defend our position' Briefing.com |
| 08:30AM | Endologix Comments on Alleged Patent Infringement GlobeNewswire |
| 20-Dec-12 05:06PM | Has Endologix Made You Any Fast Money? at Motley Fool |
| 18-Dec-12 12:03PM | Weekly CFO Sells Highlight: ELGX, LOW, NWS, SBUX, WLP at Forbes |
| 04-Dec-12 03:54PM | ENDOLOGIX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 03:36PM | CFO Moves: Xstrata, Heritage Oaks Bancorp, Endologix at The Wall Street Journal |
| 09:10AM | Endologix announces retirement of CFO Robert Krist at theflyonthewall.com |
| 09:02AM | InPlay: Endologix announces CFO retirement Briefing.com |
| 09:00AM | Endologix Announces CFO Retirement GlobeNewswire |
| 28-Nov-12 03:40PM | ENDOLOGIX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 23-Nov-12 01:06AM | A Hidden Reason Endologix's Future Looks Bright at Motley Fool |
| 14-Nov-12 04:35PM | Endologix's CEO Presents at Lazard Capital Markets 9th Annual Healthcare Conference (Transcript) at Seeking Alpha |
| 07-Nov-12 04:21PM | Endologix Is Priced For Acquisition at Seeking Alpha |
| 01:04PM | ENDOLOGIX INC /DE/ Financials EDGAR Online Financials |
| 06-Nov-12 09:00AM | Endologix to Participate in Several Upcoming Investor Conferences GlobeNewswire |
| 01:07AM | Will Endologix Fall Short Next Quarter? at Motley Fool |
| 01-Nov-12 06:02AM | ENDOLOGIX INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 27-Oct-12 09:41AM | New Star Analyst Rankings for Endologix, Inc. StarMine |
| 26-Oct-12 09:50AM | New Star Analyst Rankings for Endologix, Inc. StarMine +5.23% |
| 25-Oct-12 08:15PM | Endologix's CEO Discusses Q3 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 04:48PM | ENDOLOGIX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online |
| 04:14PM | InPlay: Endologix beats by $0.01, reports revs in-line; guides FY12 EPS in-line, revs in-line Briefing.com |
| 04:05PM | Endologix Reports 20% Revenue Growth for the Third Quarter 2012 GlobeNewswire |
| 07:07AM | Q3 2012 Endologix Inc. Earnings Release - After Market Close CCBN |
| 17-Oct-12 04:05PM | Endologix to Report Third Quarter 2012 Financial Results on October 25, 2012 GlobeNewswire |
| 09:02AM | InPlay: Endologix settles patent litigation with Cook Medical; no financial details given Briefing.com |
| 09:00AM | Endologix Settles Patent Litigation With Cook Medical GlobeNewswire |
| 06:01AM | ENDOLOGIX INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online |
| 03-Oct-12 01:50PM | ENDOLOGIX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 01-Oct-12 08:30AM | Endologix Appoints Charles Love Vice President of Clinical Affairs GlobeNewswire |
| 14-Sep-12 08:50AM | 1 Reason Endologix's Earnings Aren't So Hot at Motley Fool |
| 12-Sep-12 08:30AM | Endologix to Participate in Lazard Capital Markets Corporate Access Day GlobeNewswire |
| 10-Sep-12 05:53PM | Endologix's CEO Presents at Morgan Stanley Healthcare Conference (Transcript) at Seeking Alpha -5.07% |
| 10:14AM | Mylan Estimated ABOVE Consensus and 4 Stock Analyses to Notice at Wall St. Cheat Sheet |
| 07-Sep-12 06:02PM | Nasdaq stocks posting largest percentage increases AP +6.05% |
| 01:45PM | Nasdaq stocks posting largest percentage increases AP |
| 12:31PM | Zimmer and More Big Movers in Healthcare on September 7, 2012 at Investopedia |
| 10:18AM | Equity Brief: Upgrades and Downgrades for September 7th: CRH, CSCO, CSX, DCT, DDMG, DNR, ELGX, EOG, EQR, EW Thomson Reuters ONE |
| 06:12AM | Endologix initiated with an Outperform at BMO Capital at theflyonthewall.com |
| 06-Sep-12 08:34AM | InPlay: Endologix receives CE Mark for Nellix endovascular aneurysm sealing system; remains on track with additional device enhancements and expected limited market introduction in Europe Q2 2013 Briefing.com |
| 08:30AM | Endologix Receives CE Mark for Nellix(R) EndoVascular Aneurysm Sealing System GlobeNewswire |
| 04-Sep-12 04:15PM | Endologix to Present at the 2012 Morgan Stanley Global Healthcare Conference GlobeNewswire +5.18% |
|
|
| Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of aortic disorders. It offers the ELG System, a stent graft and delivery system for the treatment of abdominal aortic aneurysms through minimally-invasive endovascular repair. The company also provides aortic extensions and limb extensions, which attach to the main body of ELG Device, enabling physicians to customize it to fit the patient's anatomy; and accessories, such as guidewires, snares, and catheter introducer sheaths that facilitate the optimal delivery of its ELG Device. Endologix, Inc. sells its products through direct sales force and a network of agents in the United States and various European countries, as well as through independent distributors other European countries, Asia, South America, and Mexico. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is headquartered in Irvine, California. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Tyler Martin | VP, International | Mar 15 | Sale | 15.43 | 28,606 | 441,513 | 14,472 | Mar 15 06:29 PM | | Tyler Martin | VP, International | Mar 14 | Sale | 15.50 | 1,394 | 21,607 | 14,472 | Mar 14 06:55 PM | | Sorsher Gary I. | Vice President - Quality | Mar 12 | Sale | 16.01 | 5,090 | 81,515 | 45,339 | Mar 12 04:08 PM | | DE GREEF RODERICK | Director | Mar 08 | Option Exercise | 6.35 | 12,000 | 76,200 | 19,102 | Mar 08 06:25 PM | | Sorsher Gary I. | Vice President - Quality | Mar 08 | Sale | 16.00 | 2,823 | 45,156 | 50,429 | Mar 11 12:41 PM | | DE GREEF RODERICK | Director | Mar 08 | Sale | 15.80 | 12,000 | 189,565 | 7,102 | Mar 08 06:25 PM | | DE GREEF RODERICK | Director | Mar 07 | Option Exercise | 7.71 | 28,000 | 216,000 | 35,102 | Mar 08 12:06 PM | | DE GREEF RODERICK | Director | Mar 07 | Sale | 15.48 | 28,000 | 433,480 | 7,102 | Mar 08 12:06 PM | | Krist Robert John | Chief Financial Officer | Dec 28 | Sale | 14.06 | 37,530 | 527,626 | 142,236 | Dec 31 01:10 PM | | Fauls Janet Mary | Vice President RA/QA/QC | Dec 13 | Option Exercise | 2.87 | 85,000 | 244,300 | 145,450 | Dec 14 02:33 PM | | Fauls Janet Mary | Vice President RA/QA/QC | Dec 13 | Sale | 13.29 | 85,000 | 1,129,650 | 60,450 | Dec 14 02:33 PM | | Krist Robert John | Chief Financial Officer | Dec 12 | Sale | 13.94 | 77,470 | 1,080,001 | 142,236 | Dec 13 05:08 PM | | WALLER GREGORY D | Director | Dec 12 | Sale | 14.08 | 4,147 | 58,390 | 7,102 | Dec 13 05:04 PM | | WALLER GREGORY D | Director | Dec 11 | Sale | 14.05 | 20,000 | 281,000 | 7,102 | Dec 12 05:02 PM | | Krist Robert John | Chief Financial Officer | Dec 11 | Sale | 14.08 | 279,300 | 3,932,914 | 142,236 | Dec 13 05:06 PM | | WALLER GREGORY D | Director | Dec 10 | Sale | 13.85 | 40,000 | 553,800 | 7,102 | Dec 12 05:02 PM | | Tyler Martin | VP, International | Nov 30 | Sale | 14.20 | 6,547 | 92,967 | 14,472 | Nov 30 07:14 PM | | Fauls Janet Mary | Vice President RA/QA/QC | Nov 23 | Option Exercise | 4.46 | 33,000 | 147,310 | 93,450 | Nov 26 12:35 PM | | Fauls Janet Mary | Vice President RA/QA/QC | Nov 23 | Sale | 13.67 | 33,000 | 451,110 | 60,450 | Nov 26 12:35 PM | | DE GREEF RODERICK | Director | Nov 19 | Option Exercise | 3.88 | 40,000 | 155,200 | 47,102 | Nov 20 01:28 PM | | Sorsher Gary I. | Vice President - Quality | Nov 19 | Sale | 13.86 | 1,363 | 18,891 | 52,777 | Nov 20 01:30 PM | | DE GREEF RODERICK | Director | Nov 19 | Sale | 13.90 | 40,000 | 556,055 | 7,102 | Nov 20 01:28 PM | | ESSEX WOODLANDS HEALTH VENTURE | 10% Owner | Nov 01 | Sale | 13.17 | 1,250,000 | 16,461,750 | 1,165,428 | Nov 05 05:16 PM | | Wilder Thomas | Director | Oct 31 | Option Exercise | 8.26 | 10,000 | 82,600 | 17,102 | Nov 01 12:13 PM | | Wilder Thomas | Director | Oct 31 | Sale | 13.56 | 10,000 | 135,600 | 7,102 | Nov 01 12:13 PM | | ESSEX WOODLANDS HEALTH VENTURE | 10% Owner | Sep 11 | Sale | 12.18 | 258,082 | 3,143,439 | 2,204,128 | Sep 12 04:07 PM | | ESSEX WOODLANDS HEALTH VENTURE | 10% Owner | Sep 10 | Sale | 12.10 | 203,810 | 2,466,101 | 2,462,210 | Sep 12 04:07 PM | | ESSEX WOODLANDS HEALTH VENTURE | 10% Owner | Sep 06 | Sale | 12.14 | 1,538,108 | 18,672,631 | 2,666,020 | Sep 07 03:40 PM | | Wilder Thomas | Director | Aug 30 | Option Exercise | 4.36 | 12,500 | 54,500 | 19,602 | Sep 04 12:39 PM | | Wilder Thomas | Director | Aug 30 | Sale | 12.02 | 12,500 | 150,250 | 7,102 | Sep 04 12:39 PM | | Abraham Todd | VP of Operations | Aug 01 | Buy | 11.69 | 1,500 | 17,533 | 30,194 | Aug 01 06:39 PM |
|
|
|
|
|
|
